Effect of Enhanced Feedback to Hospitals in an Emerging Clinical Information Network
Launched by KEMRI-WELLCOME TRUST COLLABORATIVE RESEARCH PROGRAM · Jun 28, 2016
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
The international guidelines for the classification and treatment of childhood pneumonia were revised recently and in Kenya the national guidelines changed in February 2016. We designed an enhanced feedback intervention aimed at improving uptake of the revised pneumonia treatment policy within a clinical network of 12 Kenyan county referral hospitals.
Hospitals were randomized to receive either enhanced feedback (n = 6 hospitals) or standard feedback (n = 6 hospitals) delivered over a six-month period following nationwide pneumonia treatment policy change. The primary outcome is the propor...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 2 to 59 months admitted to participating network hospitals with WHO pneumonia diagnosis eligible for treatment with oral amoxicillin
- Exclusion Criteria:
- • Children aged 2 to 59 months with WHO pneumonia diagnosis and co-morbid illnesses requiring intravenous antibiotic treatment including severe acute malnutrition, bacteraemia, meningitis, or
- • children presenting with pneumonia and tuberculosis or cough lasting more than 2 weeks, or severe malaria
About Kemri Wellcome Trust Collaborative Research Program
The Kemri-Wellcome Trust Collaborative Research Programme (KWTRP) is a leading clinical research organization based in Kenya, dedicated to advancing global health through innovative research and collaboration. Established as a partnership between the Kenya Medical Research Institute (KEMRI) and the Wellcome Trust, KWTRP focuses on addressing pressing health challenges, particularly infectious diseases, by conducting high-quality clinical trials and epidemiological studies. The program emphasizes capacity building, training, and community engagement, fostering a multidisciplinary approach that integrates science, health policy, and practice to improve health outcomes in Africa and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kisumu, , Kenya
Busia, , Kenya
Embu, , Kenya
Kakamega, , Kenya
Kakamega, , Kenya
Karatina, , Kenya
Kerugoya, , Kenya
Kiambu, , Kenya
Kitale, , Kenya
Machakos, , Kenya
Nairobi, , Kenya
Nyeri, , Kenya
Patients applied
Trial Officials
Mike English, MD
Principal Investigator
KEMRI-Wellcome Trust Research Priogramme
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials